Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Regenxbio Inc (NASDAQ: RGNX) closed the day trading at $7.30 down -0.27% from the previous closing price of $7.32. In other words, the price has decreased by -$0.27 from its previous closing price. On the day, 0.69 million shares were traded. RGNX stock price reached its highest trading level at $7.74 during the session, while it also had its lowest trading level at $7.23.
Ratios:
For a better understanding of RGNX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.05 and its Current Ratio is at 3.05. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Neutral and sets its target price to $14 from $38 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 30 ’24 when VITTAL VASISTA bought 20,041 shares for $7.41 per share.
KARABELAS ARGERIS N sold 10,000 shares of RGNX for $101,052 on Oct 01 ’24. The Director now owns 11,286 shares after completing the transaction at $10.11 per share. On Sep 03 ’24, another insider, KARABELAS ARGERIS N, who serves as the Director of the company, sold 10,000 shares for $11.56 each. As a result, the insider received 115,588 and left with 11,286 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 361679232 and an Enterprise Value of 252030016. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.29 while its Price-to-Book (P/B) ratio in mrq is 1.20. Its current Enterprise Value per Revenue stands at 2.989 whereas that against EBITDA is -1.127.
Stock Price History:
The Beta on a monthly basis for RGNX is 1.33, which has changed by -0.6062567 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, RGNX has reached a high of $28.80, while it has fallen to a 52-week low of $6.56. The 50-Day Moving Average of the stock is -8.78%, while the 200-Day Moving Average is calculated to be -34.21%.
Shares Statistics:
Over the past 3-months, RGNX traded about 1.31M shares per day on average, while over the past 10 days, RGNX traded about 714970 shares per day. A total of 49.53M shares are outstanding, with a floating share count of 44.66M. Insiders hold about 9.84% of the company’s shares, while institutions hold 87.29% stake in the company. Shares short for RGNX as of 1738281600 were 6408552 with a Short Ratio of 4.88, compared to 1735603200 on 6042356. Therefore, it implies a Short% of Shares Outstanding of 6408552 and a Short% of Float of 16.91.
